Joanna McGlashan

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK

Merryn Voysey, Sue Ann Costa Clemens, Shabir A. Madhi et al. · The Lancet · 2020 · 5K citations · Full text

Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials

Merryn Voysey, Sue Ann Costa Clemens, Shabir A. Madhi et al. · The Lancet · 2021 · 1.2K citations · Full text

Expression, purification and cell cytotoxicity of actin-modifying binary toxin from Clostridium difficile

Amit Sundriyal, April K. Roberts, Roger Ling et al. · Protein Expression and Purification · 2010 · 41 citations

Microbial Toxin, Actin-modifying Binary Toxin, Toxinology +6

Bivalent Recombinant Vaccine for Botulinum Neurotoxin Types A and B Based on a Polypeptide Comprising Their Effector and Translocation Domains That Is Protective against the Predominant A and B Subtypes

Clifford C. Shone, Heidi Agostini, Joanna Clancy et al. · Infection and Immunity · 2009 · 37 citations · Full text

Engineering, Bivalent Recombinant Vaccine, Immunology +21

Development and Evaluation of an Ovine Antibody-Based Platform for Treatment of Clostridium difficile Infection

April K. Roberts, Joanna McGlashan, Ibrahim Al‐Abdulla et al. · Infection and Immunity · 2011 · 36 citations · Full text

Veterinary Vaccine, Microbial Toxin, Antimicrobial Susceptibility +14